Skip to main content
Top
Published in: BMC Nephrology 1/2022

Open Access 01-12-2022 | Microalbuminuria | Research article

A comparison of the utility of the urine dipstick and urine protein-to-creatinine ratio for predicting microalbuminuria in patients with non-diabetic lifestyle-related diseases -a comparison with diabetes

Authors: Makoto Ogi, Takuya Seto, Yoshinori Wakabayashi

Published in: BMC Nephrology | Issue 1/2022

Login to get access

Abstract

Background

The utility of dipstick proteinuria for predicting microalbuminuria in non-diabetic lifestyle-related diseases compared with the urine protein-to-creatinine ratio (uPCR) and the effect of dipstick proteinuria on the cut-off value (CO) and accuracy of uPCR are unclear.

Methods

The subjects included Japanese patients ≥ 18 years old with lifestyle-related diseases who had an estimated glomerular filtration rate of ≥ 15 ml/min/1.73 m2 and uPCR of < 0.5 g/gCr at initiation. Urine dipstick, uPCR and urine albumin-to-creatinine ratio (uACR) were measured three times per case. Microalbuminuria was defined as uACR of 30–299 mg/gCr for at least 2 of 3 measurements. Youden’s Index was used as the optimal CO. Factors associated with microalbuminuria were analyzed using a logistic regression model.

Results

In 313 non-diabetic cases (median 70.8 years old), 3 dipstick proteinuria measurements were independently useful for detecting microalbuminuria, and the CO was set when a trace finding was obtained at least 1 of 3 times (sensitivity 0.56, specificity 0.80, positive predictive value [PPV] 0.73, negative predictive value [NPV] 0.65). A single uPCR measurement was more useful than 3 dipstick measurements, and was useful for detecting microalbuminuria even in cases with three consecutive negative proteinuria findings, indicating that the CO of the second uPCR with G1-3a (n = 136) was 0.06 g/gCr (sensitivity 0.76, specificity 0.84. PPV 0.68, NPV 0.89), while that with G3-b4 (n = 59) was 0.10 g/gCr (sensitivity 0.56, specificity 0.91. PPV 0.83, NPV 0.71). The sum of 3 uPCRs was useful for detecting microalbuminuria in cases with G1-3a (sensitivity 0.67, specificity 0.94, PPV 0.82, NPV 0.86) and G3b-4 (sensitivity 0.78, specificity 0.94, PPV 0.91 NPV 0.83), with both COs being 0.23 g/gCr. These COs of microalbuminuria did not change when trace or more proteinuria was included, although the sensitivity increased. A high uPCR and low urine specific gravity or creatinine level were independent factors for uACR ≥ 30 mg/gCr in cases with negative proteinuria, although the uPCR was a major predictive factor of a uACR ≥ 30 mg/gCr.

Conclusions

The uPCR (preferably determined using early-morning urine), including in dipstick-negative proteinuria cases with non-diabetic lifestyle-related diseases, can aid in the early detection of microalbuminuria.

Trial registration

Retrospectively registered.
Appendix
Available only for authorised users
Literature
1.
go back to reference Levey AS, de Jong PE, Coresh J, Nahas ME, Astor BC, Matsushita K, Gansevoort RT, Kasiske BL, Eckardt KU. The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int. 2011;80:17–28.CrossRefPubMed Levey AS, de Jong PE, Coresh J, Nahas ME, Astor BC, Matsushita K, Gansevoort RT, Kasiske BL, Eckardt KU. The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int. 2011;80:17–28.CrossRefPubMed
2.
go back to reference Japanease Society of Nephrology. Evidence-based Clinical Practice Guideline for CKD 2013. Clin Exp Nephrol. 2014;18:346–423.CrossRef Japanease Society of Nephrology. Evidence-based Clinical Practice Guideline for CKD 2013. Clin Exp Nephrol. 2014;18:346–423.CrossRef
3.
go back to reference Kidney Disease: Improving Global Outcomes. KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Supp. 2013;3:19–90. Kidney Disease: Improving Global Outcomes. KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Supp. 2013;3:19–90.
4.
go back to reference Wada T, Haneda M, Furuichi K, Babazono T, Yokoyama H, Iseki K, Araki S, Ninomiya T, Hara S, Suzuki Y, Iwano M, Kusano E, Moriya T, Satoh H, Nakamura H, Shimizu M, Toyama T, Hara A, Makino H, The research group of diabetic nephropathy, Ministry of Health, Labour, and Welfare of Japan. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes. Clin Exp Nephrol. 2014;18:613–20.CrossRefPubMed Wada T, Haneda M, Furuichi K, Babazono T, Yokoyama H, Iseki K, Araki S, Ninomiya T, Hara S, Suzuki Y, Iwano M, Kusano E, Moriya T, Satoh H, Nakamura H, Shimizu M, Toyama T, Hara A, Makino H, The research group of diabetic nephropathy, Ministry of Health, Labour, and Welfare of Japan. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes. Clin Exp Nephrol. 2014;18:613–20.CrossRefPubMed
5.
go back to reference Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetics and nondiabetic individuals. JAMA. 2001;286:421–6.CrossRefPubMed Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetics and nondiabetic individuals. JAMA. 2001;286:421–6.CrossRefPubMed
6.
go back to reference Yokoyama H, Araki S, Haneda M, Matsushima M, Kawai K, Hirano K, Oishi M, Sugimoto K, Sone H, Maegawa H, Kashiwagi A, for the Japan Diabetes Clinical Data Management Study Group. Chronic kidney disease categories and renal-cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25). Diabetologia. 2012;55:1911–8.CrossRefPubMed Yokoyama H, Araki S, Haneda M, Matsushima M, Kawai K, Hirano K, Oishi M, Sugimoto K, Sone H, Maegawa H, Kashiwagi A, for the Japan Diabetes Clinical Data Management Study Group. Chronic kidney disease categories and renal-cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25). Diabetologia. 2012;55:1911–8.CrossRefPubMed
7.
go back to reference Li H, Zhao S, Wang R, Gao B. The association between cognitive impairment/dementia and albuminuria: a systematic review and meta-analysis. Clin Exp Nephrol. 2022;26:45–53.CrossRefPubMed Li H, Zhao S, Wang R, Gao B. The association between cognitive impairment/dementia and albuminuria: a systematic review and meta-analysis. Clin Exp Nephrol. 2022;26:45–53.CrossRefPubMed
8.
go back to reference Mount DB. Azotemia and urinary abnormalities. In: Jameson JL, Kasper DL, Longo DL, Fauci AS, Hauser SL, Loscalzo J, editors. Harrison’s principles of internal medicine. USA: McGraw-Hill Education; 2018. 288–95. Mount DB. Azotemia and urinary abnormalities. In: Jameson JL, Kasper DL, Longo DL, Fauci AS, Hauser SL, Loscalzo J, editors. Harrison’s principles of internal medicine. USA: McGraw-Hill Education; 2018. 288–95.
9.
go back to reference Nitta K, Goto S, Masakane I, Hanafusa N, Taniguchi M, Hasegawa T, Nakai S, Wada A, Hamano T, Hoshino J, Joki N, Abe M, Yamamoto K, Nakamoto H, Japanese Society for Dialysis Therapy Renal Data Registry Committee. Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality. Renal Replacement Therapy. 2020;6:41. https://doi.org/10.1186/s41100-020-00286-9.CrossRef Nitta K, Goto S, Masakane I, Hanafusa N, Taniguchi M, Hasegawa T, Nakai S, Wada A, Hamano T, Hoshino J, Joki N, Abe M, Yamamoto K, Nakamoto H, Japanese Society for Dialysis Therapy Renal Data Registry Committee. Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality. Renal Replacement Therapy. 2020;6:41. https://​doi.​org/​10.​1186/​s41100-020-00286-9.CrossRef
10.
go back to reference Cherney DZI, Verma S. DAPA-CKD The beginning of a new era in renal protection. JACC Basic Trans Sci. 2021;6:74–7.CrossRef Cherney DZI, Verma S. DAPA-CKD The beginning of a new era in renal protection. JACC Basic Trans Sci. 2021;6:74–7.CrossRef
11.
go back to reference Konta T, Hao Z, Takasaki S, Abiko H, Ishikawa M, Takahashi T, Ikeda A, Ichikawa K, Kato T, Kawata S, Kubota I. Clinical utility of trace proteinuria for microalbuminuria screening in the general population. Clin Exp Nephrol. 2007;11:51–5.CrossRefPubMed Konta T, Hao Z, Takasaki S, Abiko H, Ishikawa M, Takahashi T, Ikeda A, Ichikawa K, Kato T, Kawata S, Kubota I. Clinical utility of trace proteinuria for microalbuminuria screening in the general population. Clin Exp Nephrol. 2007;11:51–5.CrossRefPubMed
12.
go back to reference White SL, Yu R, Craig JC, Polkinghorne KR, Atkins RC, Chadban SJ. Diagnostic accuracy of urine dipsticks for detection of albuminuria in the general community. Am J Kidney Dis. 2011;58:19–28.CrossRefPubMed White SL, Yu R, Craig JC, Polkinghorne KR, Atkins RC, Chadban SJ. Diagnostic accuracy of urine dipsticks for detection of albuminuria in the general community. Am J Kidney Dis. 2011;58:19–28.CrossRefPubMed
13.
go back to reference Park JI, Baek H, Kim BR, Jung HH. Comparison of urine dipstick and albumin: creatinine ratio for chronic kidney disease screening: A population-based study. PLoS One. 2017;12: e0171106.CrossRefPubMedPubMedCentral Park JI, Baek H, Kim BR, Jung HH. Comparison of urine dipstick and albumin: creatinine ratio for chronic kidney disease screening: A population-based study. PLoS One. 2017;12: e0171106.CrossRefPubMedPubMedCentral
14.
go back to reference Sumida K, Nadkarni GN, Grams ME, Sang Y, Ballew SH, Coresh J, Matsushitab K, Surapaneni A, Brunskill N, Chdban SJ, Chang AR, Cirillo M, Daratha KB, Gansevoort RT, Garg AX, Iacoviell L, Kayama T, Konta T, Kvesdy CP, Lash J, Lee BJ, Major RW, Metzger M, Miura K, Naimark DMJ, Nelson RG, Sawhney S, Stempniewicz N, Tang M, Townsend RR, Traynor JP, Valdivielso JM, Wetzels J, Polkinghorne KR, Heerspink HJL, Chronic Kidney Disease Prognosis Consortium. Conversion of urine protein-creatinine ratio or urine dipstick protein to urine albumin-creatinine ratio for use in chronic kidney disease screening and prognosis: an individual participant-based meta-analysis. Ann Intern Med. 2020;173:426–35.CrossRefPubMedPubMedCentral Sumida K, Nadkarni GN, Grams ME, Sang Y, Ballew SH, Coresh J, Matsushitab K, Surapaneni A, Brunskill N, Chdban SJ, Chang AR, Cirillo M, Daratha KB, Gansevoort RT, Garg AX, Iacoviell L, Kayama T, Konta T, Kvesdy CP, Lash J, Lee BJ, Major RW, Metzger M, Miura K, Naimark DMJ, Nelson RG, Sawhney S, Stempniewicz N, Tang M, Townsend RR, Traynor JP, Valdivielso JM, Wetzels J, Polkinghorne KR, Heerspink HJL, Chronic Kidney Disease Prognosis Consortium. Conversion of urine protein-creatinine ratio or urine dipstick protein to urine albumin-creatinine ratio for use in chronic kidney disease screening and prognosis: an individual participant-based meta-analysis. Ann Intern Med. 2020;173:426–35.CrossRefPubMedPubMedCentral
15.
go back to reference Nagai K, Yamagata K. Quantitative evaluation of proteinuria for health checkups is more efficient than the dipstick method. Clin Exp Nephrol. 2015;19:152–3.CrossRefPubMed Nagai K, Yamagata K. Quantitative evaluation of proteinuria for health checkups is more efficient than the dipstick method. Clin Exp Nephrol. 2015;19:152–3.CrossRefPubMed
16.
go back to reference Yamamoto K, Yamamoto H, Yoshida K, Niwa K, Nishi Y, Mizuno A, Kuwabara M, Asano T, Sakoda K, Niinuma H, Nakahara F, Takeda K, Shindoh C, Komatsu Y. The total urine protein-to-creatinine ratio can predict the presence of microalbuminuria. PLoS One. 2014;9:e91067.CrossRefPubMedPubMedCentral Yamamoto K, Yamamoto H, Yoshida K, Niwa K, Nishi Y, Mizuno A, Kuwabara M, Asano T, Sakoda K, Niinuma H, Nakahara F, Takeda K, Shindoh C, Komatsu Y. The total urine protein-to-creatinine ratio can predict the presence of microalbuminuria. PLoS One. 2014;9:e91067.CrossRefPubMedPubMedCentral
17.
go back to reference Weaver RG, James MT, Ravani P, Weaver CGW, Lamb EJ, Tonelli M, Manns BJ, Quinn RR, Jun M, Hemmelgarn BR. Estimating urine albumin-to-creatinine ratio from protein-to-creatinine ratio: development of equations using same-day measurements. J Am Soc Nephrol. 2020;31:591–601.CrossRefPubMedPubMedCentral Weaver RG, James MT, Ravani P, Weaver CGW, Lamb EJ, Tonelli M, Manns BJ, Quinn RR, Jun M, Hemmelgarn BR. Estimating urine albumin-to-creatinine ratio from protein-to-creatinine ratio: development of equations using same-day measurements. J Am Soc Nephrol. 2020;31:591–601.CrossRefPubMedPubMedCentral
18.
go back to reference Ogi M, Seto T, Wakabayashi Y. Prediction of microalbuminuria from proteinuria in chronic kidney disease due to non-diabetic lifestyle-related diseases: comparison with diabetes. Clin Exp Nephrol. 2021;25:727–50.CrossRefPubMedPubMedCentral Ogi M, Seto T, Wakabayashi Y. Prediction of microalbuminuria from proteinuria in chronic kidney disease due to non-diabetic lifestyle-related diseases: comparison with diabetes. Clin Exp Nephrol. 2021;25:727–50.CrossRefPubMedPubMedCentral
19.
go back to reference Zhou XH, Obuchowski NA, McClish DK. Measures of diagnostic accuracy. In: Statistical methods in diagnostic medicine. Second edition. New Jersey: John Wiley & Sons, Inc.; 2011. 13–55.CrossRef Zhou XH, Obuchowski NA, McClish DK. Measures of diagnostic accuracy. In: Statistical methods in diagnostic medicine. Second edition. New Jersey: John Wiley & Sons, Inc.; 2011. 13–55.CrossRef
20.
go back to reference Lamb EJ, MacKenzie F, Stevens PE. How should proteinuria be detected and measured? Ann Clin Biochem. 2009;46:205–17.CrossRefPubMed Lamb EJ, MacKenzie F, Stevens PE. How should proteinuria be detected and measured? Ann Clin Biochem. 2009;46:205–17.CrossRefPubMed
21.
go back to reference Christen EI, Nielsen R, Birn H. Renal filtration,transport, and metabolism of albumin and albuminuria. In: Seldin and Giebisch‘s the kidney physiology and pathophysiology. USA: Elsevier Inc; 2013. 2457–74. Christen EI, Nielsen R, Birn H. Renal filtration,transport, and metabolism of albumin and albuminuria. In: Seldin and Giebisch‘s the kidney physiology and pathophysiology. USA: Elsevier Inc; 2013. 2457–74.
22.
go back to reference Witte EC, Lambers Heerspink HJ, de Zeeuw D, Bakker SJL, deJong PE, Gansevoort R. First morning voids are more reliable than spot samples to assess microalbuminuria. J Am Soc Nephrol. 2009;20:436–43.CrossRefPubMedPubMedCentral Witte EC, Lambers Heerspink HJ, de Zeeuw D, Bakker SJL, deJong PE, Gansevoort R. First morning voids are more reliable than spot samples to assess microalbuminuria. J Am Soc Nephrol. 2009;20:436–43.CrossRefPubMedPubMedCentral
23.
go back to reference Ikizler TP, Greene JH, Wingard RL, Parker RA, Hakim RA. Spontaneous dietary protein intake during progression of chronic renal failure. J Am Soc Nephrol. 1995;6:1386–91.CrossRefPubMed Ikizler TP, Greene JH, Wingard RL, Parker RA, Hakim RA. Spontaneous dietary protein intake during progression of chronic renal failure. J Am Soc Nephrol. 1995;6:1386–91.CrossRefPubMed
24.
go back to reference Moon SJ, Kim TH, Yoon SY, Chung JH, Hwang HJ. Relationship between stage of chronic kidney disease and sarcopenia in Korean aged 40 years and older using the Korea National Health and Nutrition Examination Surveys (KNHANES IV-2,3, and V-1,2), 2008–2011. PLoS One. 2015;10:e0130740.CrossRefPubMedPubMedCentral Moon SJ, Kim TH, Yoon SY, Chung JH, Hwang HJ. Relationship between stage of chronic kidney disease and sarcopenia in Korean aged 40 years and older using the Korea National Health and Nutrition Examination Surveys (KNHANES IV-2,3, and V-1,2), 2008–2011. PLoS One. 2015;10:e0130740.CrossRefPubMedPubMedCentral
25.
go back to reference Fotheringham J, Campbell MJ, Fogarty DG, Nahas ME, Ellam T. Estimated albumin excretion rate versus urine albumin-creatinine ratio for the estimation of measured albumin excretion rate: derivation and validation of an estimated albumin excretion rate equation. Am J Kidney Dis. 2014;63:405–14.CrossRefPubMed Fotheringham J, Campbell MJ, Fogarty DG, Nahas ME, Ellam T. Estimated albumin excretion rate versus urine albumin-creatinine ratio for the estimation of measured albumin excretion rate: derivation and validation of an estimated albumin excretion rate equation. Am J Kidney Dis. 2014;63:405–14.CrossRefPubMed
27.
go back to reference Thomas MC, Moran J, MacIsaac R, Shaw JE, Jerums G, Atkins RC, Weeks A. Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (National evaluation of the frequency of renal impairment coexisting with NIDDM[NEFRON]11). Diabetes Care. 2009;32:1497–502.CrossRefPubMedPubMedCentral Thomas MC, Moran J, MacIsaac R, Shaw JE, Jerums G, Atkins RC, Weeks A. Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (National evaluation of the frequency of renal impairment coexisting with NIDDM[NEFRON]11). Diabetes Care. 2009;32:1497–502.CrossRefPubMedPubMedCentral
28.
go back to reference Pengfei Z, Lewington S, Haynes R, Emberson J, Landray MJ, Cherney D, Woodward M, Baigent C, Herrington WG, Staplin N. Cross-sectional associations between central and general adiposity with albuminuria: observations from 400,000 people in UK Biobank. Int J Obes. 2020;44:2256–66.CrossRef Pengfei Z, Lewington S, Haynes R, Emberson J, Landray MJ, Cherney D, Woodward M, Baigent C, Herrington WG, Staplin N. Cross-sectional associations between central and general adiposity with albuminuria: observations from 400,000 people in UK Biobank. Int J Obes. 2020;44:2256–66.CrossRef
29.
go back to reference Furuichi K, Shimizu M, Okada H, Narita I, Wada T. Clinico-pathological features of kidney disease in diabetic cases. Clin Exp Nephrol. 2018;22:1046–51.CrossRefPubMedPubMedCentral Furuichi K, Shimizu M, Okada H, Narita I, Wada T. Clinico-pathological features of kidney disease in diabetic cases. Clin Exp Nephrol. 2018;22:1046–51.CrossRefPubMedPubMedCentral
30.
go back to reference Yatsuya H, Li Y, Hirakawa Y, Ota A, Matsunaga M, Haregot HE, Chiang C, Zhang Y, Tamakoshi K, Toyoshima H, Aoyama A. A point system for predicting 10-year risk of developing type 2 diabetes mellitus in japanese men: Aichi worker’s cohort study. J Epidemiol. 2018;28:347–52.CrossRefPubMedPubMedCentral Yatsuya H, Li Y, Hirakawa Y, Ota A, Matsunaga M, Haregot HE, Chiang C, Zhang Y, Tamakoshi K, Toyoshima H, Aoyama A. A point system for predicting 10-year risk of developing type 2 diabetes mellitus in japanese men: Aichi worker’s cohort study. J Epidemiol. 2018;28:347–52.CrossRefPubMedPubMedCentral
31.
go back to reference Eckel RH. The metabolic syndrome. In: Jameson JL, Kasper DL, Longo DL, AS Fauci, Hauser SL, Loscalzo J, editors. Harrison’s principles of internal medicine. USA: McGraw-Hill Education; 2018. 2903–9. Eckel RH. The metabolic syndrome. In: Jameson JL, Kasper DL, Longo DL, AS Fauci, Hauser SL, Loscalzo J, editors. Harrison’s principles of internal medicine. USA: McGraw-Hill Education; 2018. 2903–9.
32.
go back to reference Yokoyama H, Shudo R, Araki S, Shimizu H, Honjo J, Sone H, Okizaki S, Moriya T, Yamada D, Haneda M. Association between remission of macroalbuminuria and preservation of renal function in patients with type 2 diabetes with overt proteinuria. Diabetes Care. 2013;36:3227–33.CrossRefPubMedPubMedCentral Yokoyama H, Shudo R, Araki S, Shimizu H, Honjo J, Sone H, Okizaki S, Moriya T, Yamada D, Haneda M. Association between remission of macroalbuminuria and preservation of renal function in patients with type 2 diabetes with overt proteinuria. Diabetes Care. 2013;36:3227–33.CrossRefPubMedPubMedCentral
33.
go back to reference Araki S, Haneda M, Sugimoto T, Isono M, Isshiki K, Kashiwagi A, Koya D. Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes. Diabetes. 2005;54:2983–7.CrossRefPubMed Araki S, Haneda M, Sugimoto T, Isono M, Isshiki K, Kashiwagi A, Koya D. Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes. Diabetes. 2005;54:2983–7.CrossRefPubMed
35.
go back to reference Jongs N, Greene T, Chertow GM, McMurray JJV, Langkilde AM, Correa-Rotter R, Rossing P, Sjostrom CD, Stefansson BV, Toto RD, Wheeler DC, Heerspink HJL, for the DAPA-CKD Trial Committees and Investigators. Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial. Lancet Diabetes Endocrinol. 2021;9:755–76.CrossRefPubMed Jongs N, Greene T, Chertow GM, McMurray JJV, Langkilde AM, Correa-Rotter R, Rossing P, Sjostrom CD, Stefansson BV, Toto RD, Wheeler DC, Heerspink HJL, for the DAPA-CKD Trial Committees and Investigators. Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial. Lancet Diabetes Endocrinol. 2021;9:755–76.CrossRefPubMed
36.
go back to reference Fisher H, Hsu C, Vittinghoff E, Lin F, Bansal N. Comparison of associations of urine protein-creatinine ratio versus albumin-creatinine ratio with complications of CKD: A cross-sectional analysis. Am J Kidney Dis. 2013;62:1102–8.CrossRefPubMed Fisher H, Hsu C, Vittinghoff E, Lin F, Bansal N. Comparison of associations of urine protein-creatinine ratio versus albumin-creatinine ratio with complications of CKD: A cross-sectional analysis. Am J Kidney Dis. 2013;62:1102–8.CrossRefPubMed
Metadata
Title
A comparison of the utility of the urine dipstick and urine protein-to-creatinine ratio for predicting microalbuminuria in patients with non-diabetic lifestyle-related diseases -a comparison with diabetes
Authors
Makoto Ogi
Takuya Seto
Yoshinori Wakabayashi
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2022
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-022-02974-6

Other articles of this Issue 1/2022

BMC Nephrology 1/2022 Go to the issue